Cargando…

Radiotherapy in testicular germ cell tumours – a literature review

Testicular germ cell tumours (GCT) represent about 1–2% of malignant in men. The essential therapeutic option for early-stage GCT is radical orchiectomy (RO), except in situations that require immediate chemotherapy in patients with a massive dissemination and unequivocally elevated levels of tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonska-Gmyrek, Joanna, Peczkowski, Piotr, Michalski, Wojciech, Poniatowska, Grazyna, Zolciak-Siwinska, Agnieszka, Kotowicz, Beata, Wiechno, Pawel, Golawska, Magdalena, Kowalska, Maria, Demkow, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701577/ https://www.ncbi.nlm.nih.gov/pubmed/29180926 http://dx.doi.org/10.5114/wo.2017.69592

Ejemplares similares

Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first‐line chemotherapy
por: Michalski, Wojciech, et al.
Publicado: (2023)

Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor
por: Wiechno, Paweł J., et al.
Publicado: (2017)

Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients
por: Jonska-Gmyrek, Joanna, et al.
Publicado: (2018)

Clinical significance of androgen secretion disorders in men with a malignancy
por: Wiechno, Pawel J., et al.
Publicado: (2017)

The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
por: Kotowicz, Beata, et al.
Publicado: (2015)

Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients
por: Kotowicz, Beata, et al.
Publicado: (2017)

Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients
por: Sikorska, Katarzyna, et al.
Publicado: (2020)

Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006)

Recent advances in testicular germ cell tumours
por: Mele, Teresa, et al.
Publicado: (2021)

Testicular Germ Cell Tumours and Proprotein Convertases
por: Velado-Eguskiza, Aitziber, et al.
Publicado: (2022)

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)

Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Clinical and genetic aspects of testicular germ cell tumours
por: Holzik, Martijn F Lutke, et al.
Publicado: (2008)

Cutaneous metastasis from testicular germ cell tumour
por: Joel, Anjana, et al.
Publicado: (2014)

Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour
por: O'Leary, C. G., et al.
Publicado: (2016)

Testicular Germ Cell Tumours—The Role of Conventional Ultrasound
por: Belfield, Jane, et al.
Publicado: (2022)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
por: Selfe, J., et al.
Publicado: (2019)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

Long-term sequelae of treatment for testicular germ cell tumours.
por: Bissett, D., et al.
Publicado: (1990)

Risk of testicular germ-cell tumours in relation to childhood physical activity
por: Cook, M B, et al.
Publicado: (2008)

Genomic copy number and expression patterns in testicular germ cell tumours
por: McIntyre, A, et al.
Publicado: (2007)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Identification of four new susceptibility loci for testicular germ cell tumour
por: Litchfield, Kevin, et al.
Publicado: (2015)

Regressed testicular germ cell tumour in a post-pubertal male
por: Pickett, Lianne, et al.
Publicado: (2022)

No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
por: Labropoulou, Vassiliki T., et al.
Publicado: (2013)

Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
por: Litchfield, Kevin, et al.
Publicado: (2015)

Diverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour
por: Das, Mrinal K., et al.
Publicado: (2022)

Bone marrow metastasis of testicular germ cell tumour: A rare case
por: Dubey, Harshita, et al.
Publicado: (2023)

Urinary incontinence after radical prostatectomy – experience of the last 100 cases
por: Sosnowski, Roman, et al.
Publicado: (2011)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
por: Fosså, S. D., et al.
Publicado: (1990)

Increased risk of testis failure in testicular germ cell tumor survivors undergoing radiotherapy
por: Ghezzi, Marco, et al.
Publicado: (2017)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004)

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_7eni2odvimp21fd75sgnsgnh6u